DS
KRTX

David Shaw’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

David Shaw’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-48,800
Closed -$15.4M – 4866
2023
Q4 		$15.4M Buy
48,800
+3,600
+8% +$700K 0.01% 1088
2023
Q3 		$7.64M Buy
45,200
+4,100
+10% +$771K 0.01% 1475
2023
Q2 		$8.91M Buy
41,100
+20,700
+101% +$4.43M 0.01% 1433
2023
Q1 		$3.71M Buy
20,400
+10,400
+104% +$1.99M ﹤0.01% 2201
2022
Q4 		$1.97M Hold
10,000
– – ﹤0.01% 2954
2022
Q3 		$2.25M Buy
+10,000
New +$2.02M ﹤0.01% 2892

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

David Shaw's KRTX Position: Q1 2024 in Review

David Shaw sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 19,131 shares — an estimated $6.06M sold.

David Shaw first reported a position in KRTX in Q4 2019 and held it in 11 quarters. The position peaked at $71.6M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • David Shaw reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 19,131 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $6.06M.
  • David Shaw first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
  • David Shaw's Karuna Therapeutics, Inc. Common Stock position peaked at $71.6M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.